NCCN Guidelines implementation in the multidisciplinary Merkel Cell Carcinoma Program at the University of Michigan
Jennifer L Schwartz1, Sandra L Wong, Scott A McLean
1From the Departments of aDermatology, bSurgery, cOtolaryngology, dRadiation Oncology, eInternal Medicine, and fPathology, University of Michigan Health System, Ann Arbor, Michigan.
Abstract:
Merkel cell carcinoma (MCC) is a rare malignancy of the skin, and prospective randomized clinical studies on management and treatment are very limited. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for MCC provide up-to-date, best evidence-based, and consensus-driven management pathways with the purpose of providing best care and outcomes. Multidisciplinary management with consensus treatment recommendations to individualize patient care within the framework of these guidelines is optimal. The University of Michigan multidisciplinary MCC program uses NCCN Guidelines in the management and treatment of its patients. This article discusses 4 patient presentations to highlight the implementation of the NCCN Guidelines for MCC at the University of Michigan.
